Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681731 · ClinicalTrials.gov registry record
Impact of Neuromonitoring During Cardiac Procedures
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 250,000
- Enrollment target
NCT02681731: Completed study, sponsored by Medtronic - MITG.
NCT02681731 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 250,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02681731 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 250,000 participants
- Enrollment target
Study Summary
Through a series of sequential analyses, retrospective database exploration looking for linkages and associations between the use of processed electroencephalogram (EEG) and/or cerebral saturation monitoring and patient outcomes post-cardiothoracic surgery will be explored.
Primary Outcome
Incidence of post-operative cognitive complications identified by International Classification of Disease (ICD-9) diagnosis code
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250,000 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-12-31 |
What the finished NCT02681731 record still lists
NCT02681731 is an observational study that tracks outcomes without assigning an intervention. Its 250,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02681731 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02681731 about?
NCT02681731 is a clinical study titled "Impact of Neuromonitoring During Cardiac Procedures". Through a series of sequential analyses, retrospective database exploration looking for linkages and associations between the use of processed electroencephalogram (EEG) and/or cerebral saturation monitoring and patient outcomes post-cardiothoracic surgery will be explored.
What is the current status of trial NCT02681731?
This trial is currently completed. The enrollment target is 250,000 participants. The study started on 2016-03. Estimated completion is 2017-12-31.
Who is sponsoring clinical trial NCT02681731?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
- NCT07314697 · 300,000 participants · NA
Arrival Time Implementation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia